title: Is dexmedetomidine the agent of choice in the resection of pheochromocytoma?
authors.affiliation: Department of Surgery, Abington Memorial Hospital, Abington, Pennsylvania 19001, USA. hpolavarapu@amh.org
authors.forename: Harsha V
authors.initials: HV
authors.lastname: Polavarapu
authors.forename: Ashwin A
authors.initials: AA
authors.lastname: Kurian
authors.forename: Robert
authors.initials: R
authors.lastname: Josloff
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage; D001794:Blood Pressure / Q000187:drug effects; D020927:Dexmedetomidine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007430:Intraoperative Care; D010535:Laparoscopy; D007828:Laryngoscopy; D008875:Middle Aged; D010643:Phenoxybenzamine / Q000008:administration & dosage; D010673:Pheochromocytoma / Q000188:drug therapy* / Q000601:surgery*; D011292:Premedication
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D018712:Analgesics, Non-Narcotic; D010643:Phenoxybenzamine; D020927:Dexmedetomidine